Alvogen & AZ signs sales agreement of 3 antibodies for breast and prostate cancer
On the 11th, Alvogen Korea(CEO Young-Hee Jang) announced the Korean exclusive sales agreement of AstraZeneca’s(CEO Liz Chatwin) antibodies, Zoladex(generic name: goserelin), Arimidex(generic name: anastrozole) and Casodex(generic name: bicalutamide). Thus, AstraZeneca Korea will supply the drugs,...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
